These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15626454)

  • 21. Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood.
    Recinos PF; Pradilla G; Thai QA; Perez M; Hdeib AM; Tamargo RJ
    Surg Neurol; 2006 Nov; 66(5):463-9; discussion 469. PubMed ID: 17084186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm.
    Khurana VG; Sohni YR; Mangrum WI; McClelland RL; O'Kane DJ; Meyer FB; Meissner I
    J Cereb Blood Flow Metab; 2004 Mar; 24(3):291-7. PubMed ID: 15091109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Perspectives of pharmacological correction of nitroxidergic vasorelaxation in subarachnoidal hemorrhage].
    Karpiuk VB; Shubich MG
    Zh Vopr Neirokhir Im N N Burdenko; 2002; (2):56-61. PubMed ID: 12214511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memantine Attenuates Delayed Vasospasm after Experimental Subarachnoid Hemorrhage via Modulating Endothelial Nitric Oxide Synthase.
    Huang CY; Wang LC; Shan YS; Pan CH; Tsai KJ
    Int J Mol Sci; 2015 Jun; 16(6):14171-80. PubMed ID: 26110388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.
    Lin CL; Dumont AS; Calisaneller T; Kwan AL; Hwong SL; Lee KS
    Surg Neurol; 2005 Sep; 64(3):201-5; discussion 205-6. PubMed ID: 16099244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New concepts regarding cerebral vasospasm: glial-centric mechanisms.
    Mutch WA
    Can J Anaesth; 2010 May; 57(5):479-89. PubMed ID: 20131107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
    Zemke D; Farooq MU; Mohammed Yahia A; Majid A
    Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits.
    Neuschmelting V; Marbacher S; Fathi AR; Jakob SM; Fandino J
    Acta Neurochir (Wien); 2009 Jul; 151(7):795-801; discussion 801-2. PubMed ID: 19415172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of vascular dysfunction after subarachnoid hemorrhage.
    Koźniewska E; Michalik R; Rafałowska J; Gadamski R; Walski M; Frontczak-Baniewicz M; Piotrowski P; Czernicki Z
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():145-60. PubMed ID: 17244946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.
    McGirt MJ; Lynch JR; Parra A; Sheng H; Pearlstein RD; Laskowitz DT; Pelligrino DA; Warner DS
    Stroke; 2002 Dec; 33(12):2950-6. PubMed ID: 12468796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers and vasospasm after aneurysmal subarachnoid hemorrhage.
    Jordan JD; Nyquist P
    Neurosurg Clin N Am; 2010 Apr; 21(2):381-91. PubMed ID: 20380977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Trimble JL; Kockler DR
    Ann Pharmacother; 2007 Dec; 41(12):2019-23. PubMed ID: 17986515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
    Liu-Deryke X; Rhoney DH
    Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm.
    Clark JF; Reilly M; Sharp FR
    J Cereb Blood Flow Metab; 2002 Apr; 22(4):472-8. PubMed ID: 11919518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide related pathophysiological changes following subarachnoid haemorrhage.
    Sabri M; Ai J; Macdonald RL
    Acta Neurochir Suppl; 2011; 110(Pt 1):105-9. PubMed ID: 21116924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.
    Kwan AL; Lin CL; Yen CP; Winardi W; Su YF; Winardi D; Dai ZK; Jeng AY; Kassell NF; Howng SL; Wang CJ
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1069-74. PubMed ID: 16741051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.
    Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ
    J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of arterial and venous wall homogenates, arterial and venous blood, and different combinations to the cerebral vasospasm in an experimental model.
    Cansever T; Canbolat A; Kiriş T; Sencer A; Civelek E; Karasu A
    Surg Neurol; 2009 May; 71(5):573-9; discussion 579. PubMed ID: 18514267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
    Ishiguro M; Wellman TL; Honda A; Russell SR; Tranmer BI; Wellman GC
    Circ Res; 2005 Mar; 96(4):419-26. PubMed ID: 15692089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.